These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2358349)

  • 1. Fifteen years of radiological protection experience in a regional radiopharmacy.
    Hilditch TE; Elliott AT; Anstee DE; Murray T
    Health Phys; 1990 Jul; 59(1):109-16. PubMed ID: 2358349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorbed radiation doses to staff after implementation of a radiopharmacy clean room.
    Ponto JA
    J Nucl Med Technol; 2014 Dec; 42(4):289-91. PubMed ID: 25168252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Finger doses for staff handling radiopharmaceuticals in nuclear medicine.
    Pant GS; Sharma SK; Rath GK
    J Nucl Med Technol; 2006 Sep; 34(3):169-73. PubMed ID: 16951286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation safety in the central radiopharmacy.
    Heller SL
    Semin Nucl Med; 1996 Apr; 26(2):107-18. PubMed ID: 8723505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of syringe shields in a nuclear medicine department.
    Harding LK; Hesslewood S; Ghose SK; Thomson WH
    Nucl Med Commun; 1985 Aug; 6(8):449-54. PubMed ID: 4069470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal dose estimates and the ICRP abdominal dose limit for occupational exposure of pregnant staff to technetium-99m and iodine-131 patients.
    Mountford PJ; Steele HR
    Eur J Nucl Med; 1995 Oct; 22(10):1173-9. PubMed ID: 8542902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of three cold kit reconstitution techniques for the reduction of hand radiation dose.
    Bogsrud TV; Herold TJ; Mahoney DW; Hung JC
    Nucl Med Commun; 1999 Aug; 20(8):761-7. PubMed ID: 10451885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonmyeloablative iodine-131 anti-B1 radioimmunotherapy as outpatient therapy.
    Gates VL; Carey JE; Siegel JA; Kaminski MS; Wahl RL
    J Nucl Med; 1998 Jul; 39(7):1230-6. PubMed ID: 9669400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staff radiation doses during eight years in a nuclear medicine radiopharmacy.
    Jansen SE; Van Aswegen A; Lötter MG; Herbst CP; Otto AC
    Nucl Med Commun; 1994 Feb; 15(2):114-8. PubMed ID: 8170638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is it safe to work with iodine-131 if you are pregnant? A risk assessment for nuclear medicine staff involved with cleaning and decontamination.
    Barber RW; Parkin A; Goldstone KE
    Nucl Med Commun; 2003 May; 24(5):571-4. PubMed ID: 12717076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary safety evaluation of a cyclotron facility for positron emission tomography imaging.
    González L; Vañó E; Cordeiro CA; Carreras JL
    Eur J Nucl Med; 1999 Aug; 26(8):894-9. PubMed ID: 10436203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive dose reconstruction methodology for former rocketdyne/atomics international radiation workers.
    Boice JD; Leggett RW; Ellis ED; Wallace PW; Mumma M; Cohen SS; Brill AB; Chadda B; Boecker BB; Yoder RC; Eckerman KF
    Health Phys; 2006 May; 90(5):409-30. PubMed ID: 16607174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential dose to nuclear medicine technologists from 99mTc-DTPA aerosol lung studies.
    Achey B; Miller K; Erdman M; King S
    Health Phys; 2004 May; 86(5 Suppl):S85-7. PubMed ID: 15069295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiological assessment of petroleum pipe scale from pipe-rattling operations.
    Hamilton IS; Arno MG; Rock JC; Berry RO; Poston JW; Cezeaux JR; Park JM
    Health Phys; 2004 Oct; 87(4):382-97. PubMed ID: 15359185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of Administering High-Dose (131) I-MIBG Therapy to Children with High-Risk Neuroblastoma Without Lead-Lined Rooms.
    Chu BP; Horan C; Basu E; Dauer L; Williamson M; Carrasquillo JA; Pandit-Taskar N; Modak S
    Pediatr Blood Cancer; 2016 May; 63(5):801-7. PubMed ID: 26773712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of extremity dose in the radiopharmacy.
    Mackenzie A
    Nucl Med Commun; 1997 Jun; 18(6):578-81. PubMed ID: 9259532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel weight-based dose threshold for 18F-NaF PET-CT imaging using advanced PET-CT systems: a potential tool for reducing radiation burden.
    Marafi F; Esmail A; Rasheed R; Alkandari F; Usmani S
    Nucl Med Commun; 2017 Sep; 38(9):764-770. PubMed ID: 28723715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical Staff Radiation Protection During Fluoroscopy-Guided Urologic Interventions.
    Galonnier F; Traxer O; Rosec M; Terrasa JB; Gouezel P; Celier D; Bassinet C; Ruffion A; Paparel P; Fiard G; Terrier JE
    J Endourol; 2016 Jun; 30(6):638-43. PubMed ID: 26987619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An assessment of annual whole-body occupational radiation exposure in Ireland (1996-2005).
    Colgan PA; Currivan L; Fenton D
    Radiat Prot Dosimetry; 2008; 128(1):12-20. PubMed ID: 17562657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of exposure of workers to ionizing radiation from radioiodine and technetium in nuclear medicine departmental facilities.
    Krajewska G; Pachocki KA
    Med Pr; 2013; 64(5):625-30. PubMed ID: 24502125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.